Stockreport

Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules

Aldeyra Therapeutics, Inc.  (ALDX) 
Last aldeyra therapeutics, inc. earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aldeyra.com/investor-relations
PDF Relative to Baseline, Signal-Finding Molecule ADX-629 Demonstrated Statistically Significant Improvement in Liver Function in Patients with Alcohol-Associated HepatitisR [Read more]